BIO
Bio-Rad Laboratories, Inc. · Healthcare
Insiders sold $136K of Bio-Rad Laboratories, Inc. in the last 12 months and bought none
BIO over the last year
BIO after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Congress
Members reported 7 trades in BIO since 2023.
Every filing
45 insider filings since 2016, newest first
Eva Anette Engelhardt · EVP, President, CDG
Giovanni Magni · EVP and Chief Strategy Officer
Giovanni Magni · EVP and Chief Strategy Officer
Michael Crowley · EVP, GBL Commercial Operations
Ronald W Hutton · VP and Treasurer
Timothy S Ernst · EVP, GC, Sec
James R Stark · VP, Corporate Controller
Annette Tumolo · EVP
John Hertia · EVP
John Hertia · EVP
John Hertia · EVP
Annette Tumolo · EVP
Michael Crowley · EVP, GBL Commercial Operations
Timothy S Ernst · EVP, GC, Sec
Michael Crowley · EVP, GBL Commercial Operations
Timothy S Ernst · EVP, GC, Sec
Christine A Tsingos · EVP and CFO
Michael Crowley · EVP, GBL Commercial Operations
James R Stark · VP, Corporate Controller
Annette Tumolo · EVP
Michael Crowley · EVP, GBL Commercial Operations
Christine A Tsingos · EVP and CFO
Michael Crowley · EVP, GBL Commercial Operations
James R Stark · VP, Corporate Controller
Giovanni Magni · EVP and Chief Strategy Officer
Shannon Hall · EVP
Michael Crowley · EVP, GBL Commercial Operations
Shannon Hall · EVP
Giovanni Magni · EVP and Chief Strategy Officer
John Goetz · EVP and COO
Michael Crowley · EVP, GBL Commercial Operations
Giovanni Magni · EVP and Chief Strategy Officer
John Goetz · EVP and COO
James R Stark · VP, Corporate Controller
John Hertia · EVP
John Hertia · EVP
John Hertia · EVP
Shannon Hall · EVP
James R Stark · VP, Corporate Controller
Michael Crowley · EVP, GBL Commercial Operations
Giovanni Magni · EVP and Chief Strategy Officer
Michael Crowley · EVP, GBL Commercial Operations
Shannon Hall · EVP
Alice N Schwartz · Director and 10% owner
Christine A Tsingos · EVP and CFO
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.